Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.
about
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsInjecting drug use: A vector for the introduction of new hepatitis C virus genotypesChronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysisMortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort studyRisk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012Drugs-Related Death Soon after Hospital-Discharge among Drug Treatment Clients in Scotland: Record Linkage, Validation, and Investigation of Risk-FactorsAPASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.The promise of record linkage for assessing the uptake of health services in resource constrained settings: a pilot study from South AfricaTrends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studyManaging chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia.Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection.A new method for assessing how sensitivity and specificity of linkage studies affects estimationHepatitis C virus infection and risk of cancer: a population-based cohort study.Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionHealth care costs associated with hepatitis C: a longitudinal cohort studyMortality among British Columbians testing for hepatitis C antibody.Hepatitis B virus epidemiology.Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study.Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report.Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort studyTreatment of patients with HCV related cirrhosis: many rewards with very few risks.Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, AustraliaThe significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smokingChronic hepatitis B: what should be the goal for new therapies?Socioeconomic status in HCV infected patients - risk and prognosis.Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection.Model of life expectancy of chronic hepatitis B carriers in an endemic region.Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problemsTreatment of HBV/HCV coinfection.Cost effectiveness of hepatitis C-related interventions targeting substance users and other high-risk groups: a systematic review.The impact of hepatitis C burden: an evidence-based approach.Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.Atherosclerosis as a possible extrahepatic manifestation of chronic hepatitis C virus infection.A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland.Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.
P2860
Q24630669-A10E47D7-3B3B-4494-AA87-F2E776398638Q26781991-67A22BE7-8B74-4CAE-8F53-E173C844CE45Q26991791-60985BD2-E5F7-4B11-942A-6F2656A4E7A1Q28479129-844A615F-F95D-4D69-8075-4B1F6438893FQ28542883-E6362E92-BFA9-40C0-A9CD-FA0C03E05C2DQ28550704-21488C44-7308-41BF-B18C-1089A1533E0DQ30250088-15B63B0C-CA24-49BD-A560-222E7E453992Q30360538-3DCFEB75-2357-4B9B-B767-2611365C7EB0Q30429470-8A83E54A-4C92-4147-96BD-ABAC35AD0243Q33294712-E8C66F5C-2335-4DF3-A636-BA393CB38CB9Q33698153-5A8FC210-1821-4CCA-BE97-FF2BA8E4940CQ33801743-B123EC04-2821-4536-9FA4-ADA29AA98C1EQ33836341-F91806CE-2D21-4245-86F3-B9C08389442CQ33915350-41162455-FC0F-4342-B8A5-44EC6E2F9162Q33961730-A28ECB92-FFD9-439A-B006-68CC0F0BB57FQ34144211-87E10E2E-19B1-47F1-B930-33F05075EB0DQ34263370-9DE9B751-048F-4383-AB8D-C3E2A2DEB21AQ34417139-7F574ADF-9CA6-473B-BA11-8061279E50A4Q34645221-13A30789-68F3-4261-B46A-39F398F1446BQ35663834-50E7C660-2A0E-4290-9BE7-6CEC4484BE1FQ35731338-006CD8F3-0633-47DF-B863-129B046871D4Q35949952-25A63168-4170-4BCF-AA0D-AD570F314E5FQ35956072-76DCD096-00C9-4480-B4D1-B22E7A0E3C08Q36000989-E555ACBE-C4D2-42E1-9CC2-631D9E3C8D94Q36142732-83B53B7E-47E0-4BFB-B411-DA56FD1E356DQ36293130-A894E5AE-B60E-4506-B4AC-3218C8559CAEQ36723994-600B380A-D39A-49ED-B3CC-3C7E35379E96Q36769986-3095B96B-CADF-4F0A-8EEB-076DD06FB124Q36918975-D27C46D9-6AF6-42D1-8373-8D04C6BA6D9CQ37060330-F2A6EA6B-1497-4865-8311-59EED613AAB8Q37529062-2BC681FD-78D3-408E-ABEE-2F24D271E469Q37583193-DDE822C5-7CA5-4A82-9DE1-C60524DB6F5EQ37625493-BD680885-4156-467A-BA80-CDACD8F27DF2Q37694558-B28483E7-3726-439D-9C84-BCA86C2C03F1Q38050834-34D0A64F-5036-4D87-9317-95DB070D5E4DQ38181631-3A11D98C-DC27-45AE-813D-900EA6F152B6Q38217418-352A01DC-5537-4D61-B9FE-DD95EBB647F6Q38276377-F33A8CC5-80B5-4BA2-8DF6-4CA8382D405BQ38385363-17615D5A-693A-4123-9985-35ABB75385AFQ38407675-0B7495D0-2E9B-4705-8255-15C65E38273A
P2860
Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Causes of death after diagnosi ...... community-based linkage study.
@en
type
label
Causes of death after diagnosi ...... community-based linkage study.
@en
prefLabel
Causes of death after diagnosi ...... community-based linkage study.
@en
P2093
P1433
P1476
Causes of death after diagnosi ...... community-based linkage study.
@en
P2093
Gregory J Dore
John M Kaldor
Mark Bartlett
Matthew G Law
P304
P356
10.1016/S0140-6736(06)69374-4
P407
P50
P577
2006-09-01T00:00:00Z